MPM BioImpact — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
BiotechSan Francisco, US
Jeanmarie Guenot(Executive Officer, Director)Florian Fischer(Director)
Board seatVinay BhaskarLuke Evnin· per SEC Form D · $7M raise · filed Jul 2017
Co-investorsQiming Healthcare
Digital data collection and clinical trial technology platform offering Direct Data Capture, eCOA, eConsent, and digital biomarkers.
Winston-Salem, US
Douglas E. Pierce, Jr.(Executive Officer, Director, Promoter)Joe Schmidt(Executive Officer)Edward S. Seguine(Executive Officer, Director, Promoter)
BoardAnsbert Gadicke(Director)inMatt King(Director)inBrad Geesaman(Director)
Board seatTony RosenbergTodd FoleyAnsbert K. Gadicke· per SEC Form D · $2.5M raise · filed Dec 2017
Co-investorsFCA Venture PartnersMcKesson Ventures
BiotechBrisbane, US
Hans Peter Gerber(Executive Officer, Director)
BoardChristopher Arendt(Director)Lori Kunkel(Director)
Board seatBard GeesamanDan HicklinLuke Evnin· per SEC Form D · $56M raise · filed Jan 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.